nDatalyze Corp (NDAT) AI Stock Analysis

• Market Cap: C$1.03M
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): 1.04
• Revenue Growth: -100.00%
• EPS Growth: 65.85%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 41,327,423
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: >-0.01
• Price to Book (P/B): 2.34
• Price to Sales (P/S): 732.04
• P/FCF Ratio: -2.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: C$0.04 ▲(95.00% Upside)

The score is held down primarily by severe fundamental deterioration—sharp revenue contraction, persistent losses, and ongoing cash burn—despite the benefit of having no debt. Technicals are supportive in trend terms (price above moving averages and positive MACD) but are extremely overextended (RSI/Stoch), and valuation offers little support given negative earnings and no dividend.

Positive Factors

Debt-free balance sheet

A zero-debt capital structure materially reduces near-term financing pressure and interest obligations. For a cash-burning business this structural conservatism preserves optionality and extends runway, lowering default risk and aiding strategic restructuring or capital raises over months.

Very high reported gross margin (2025)

A ~91% gross margin suggests the core service/product has low variable costs, enabling strong operating leverage if revenue recovers. Sustainably high gross margins provide a clear path to profitability once fixed costs are controlled or top line returns, improving long-term margin durability.

Prior ability to generate positive cash flow

Historic periods of positive operating/free cash flow indicate the business model can self-fund under the right conditions. This demonstrates operational feasibility and gives credibility to a recovery plan: cost or revenue fixes could restore cash generation within several quarters.

Negative Factors

Severe revenue collapse

An extreme top-line decline of this magnitude signals loss of customers, product-market fit, or core contracts. Such structural revenue erosion destroys operating leverage, makes fixed costs unsustainable, and implies rebuilding sales is required for any durable recovery over the next several months.

Sustained negative free cash flow

Large, persistent negative free cash flow indicates ongoing cash burn that depletes reserves and forces external financing or dilution. With FCF tracking negative net income, losses are translating into real cash outflows that pressure liquidity and constrain investment or recovery initiatives.

Eroding shareholders' equity

Rapid decline in equity reflects cumulative losses and weak returns on invested capital, reducing the balance-sheet buffer against shocks. A diminished capital base limits capacity to fund operations or growth internally and raises the likelihood of dilutive financing or restructuring needs.

nDatalyze Corp Business Overview & Revenue Model

Company Description

nDatalyze Corp (NDAT) is a technology-driven company operating in the healthcare sector. It focuses on developing innovative mental health diagnostic tools and platforms leveraging artificial intelligence and machine learning technologies. The company's core product, the YMI (Your Mental Insight) platform, aims to provide predictive insights and personalized mental health assessments to enhance mental healthcare delivery.

How the Company Makes Money

nDatalyze Corp generates revenue primarily through subscription-based access to its YMI platform. Healthcare providers, clinics, and individual users subscribe to the platform for its mental health assessment tools, which utilize advanced data analytics to offer personalized insights and recommendations. The company may also explore partnerships with healthcare organizations and technology firms to expand its market reach and enhance its service offerings. Additionally, nDatalyze may engage in research collaborations or licensing agreements to further monetize its proprietary technologies and data assets.

nDatalyze Corp Financial Statement Overview

Summary

Overall fundamentals are weak. Revenue has collapsed (662,768 in 2021 to 1,714 in 2025) and the company remains deeply unprofitable with recurring negative operating and free cash flow (2025 FCF: -466,136). The main offsetting positive is a debt-free balance sheet, though equity has eroded materially over time.

Income Statement

Revenue has collapsed over time (from 662,768 in 2021 to 1,714 in 2025), and profitability has deteriorated sharply. While 2025 shows an unusually high gross margin (~91%), the company is deeply unprofitable with extremely negative operating and net margins, indicating the cost structure is not supported by the current revenue base. Losses improved versus 2023 in absolute terms, but the business remains far from breakeven and top-line momentum is the primary weakness.

Balance Sheet

The balance sheet is conservatively levered with no debt across all reported periods, which meaningfully reduces financial risk. However, equity has declined from 1,629,305 (2022) to 536,163 (2025), reflecting ongoing losses and erosion of the capital base. Returns on equity are consistently negative, so despite low leverage, the key weakness is the company’s inability to generate profits on its equity.

Cash Flow

Cash generation is weak: operating cash flow and free cash flow are negative in 2022–2025, including -466,136 of free cash flow in 2025. The business briefly generated positive operating/free cash flow in 2020–2021, but the trend reversed meaningfully, suggesting rising cash burn and reduced self-funding capacity. Free cash flow tracks net income closely (ratios near ~1), but both are negative—highlighting that losses are translating into cash outflows.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.71K	96.34K	171.22K	424.93K	531.17K
Gross Profit	1.55K	67.39K	44.84K	229.98K	316.92K
EBITDA	-636.00K	-429.24K	-1.23M	-1.17M	-25.69K
Net Income	-554.48K	-155.60K	-1.23M	-1.17M	-36.60K
Balance Sheet
Total Assets	560.64K	877.91K	862.01K	1.71M	673.84K
Cash, Cash Equivalents and Short-Term Investments	522.96K	794.10K	742.74K	1.60M	594.49K
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Liabilities	24.48K	38.26K	289.27K	81.42K	36.92K
Stockholders Equity	536.16K	839.65K	572.74K	1.63M	636.92K
Cash Flow
Free Cash Flow	-466.14K	-221.64K	-1.03M	-1.14M	90.36K
Operating Cash Flow	-466.14K	-217.46K	-1.02M	-1.13M	92.12K
Investing Cash Flow	0.00	-4.17K	-4.39K	-13.85K	-1.75K
Financing Cash Flow	194.99K	273.00K	175.54K	1.95M	360.64K

nDatalyze Corp Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NDAT, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 43.70 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:NDAT.

nDatalyze Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	68 Neutral	C$517.04M	159.66	1.45%	―	59.34%	-23.48%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ADK	50 Neutral	C$35.52M	-6.18	―	―	-48.53%	-9.66%
AIDR	48 Neutral	C$62.88M	-4.24	-207.53%	―	―	7.04%
NDAT	46 Neutral	C$1.03M	-3.38	-40.64%	―	-100.00%	65.85%
UDOC	44 Neutral	C$12.09M	-2.43	―	―	―	48.94%

nDatalyze Corp Corporate Events

nDatalyze Ends FoodCo RTO, Refocuses on Hockey Analytics App and CSE Listing

nDatalyze Corp. has terminated its proposed reverse takeover transaction with a Vancouver-based private company referred to as FoodCo, citing ongoing delays and FoodCo’s default on certain terms of their binding memorandum of understanding signed in August 2025. The company said it will continue to commercialize its Epitome hockey-focused predictive performance app, seek alternative reverse takeover candidates, and intends to apply for reinstatement of trading of its shares on the Canadian Securities Exchange, a move that may help stabilize its capital markets profile and preserve strategic flexibility following the collapse of the FoodCo deal.

The most recent analyst rating on (TSE:NDAT) stock is a Sell with a C$0.01 price target. To see the full list of analyst forecasts on nDatalyze Corp stock, see the TSE:NDAT Stock Forecast page.

nDatalyze Corp. Advances Epitome Sports Analytics Platform with Key Milestone Completion

nDatalyze Corp. has completed a significant milestone for its Epitome sports analytics platform by finalizing data collection and calibration across multiple hockey teams. This achievement validates the platform’s analytical frameworks, reducing technical risks and paving the way for market analysis and commercialization. Epitome is designed to support personalized athlete development and organizational decision-making by providing insights into factors influencing long-term performance, rather than predicting specific outcomes. The company plans to focus on market segmentation and commercialization strategies targeting specialized hockey academies, junior teams, athlete parents, and scouts.

nDatalyze Corp. Receives Additional Deposit for RTO Progress

nDatalyze Corp., a company listed on the Canadian Securities Exchange, has announced an update regarding its Reverse Takeover (RTO) progress. The company has received an additional $20,000 good faith deposit from the RTO target, indicating continued commitment despite delays related to audit and tax opinion. Trading of the corporation’s shares will remain halted until the RTO is either completed or abandoned.